Department of Ophthalmology , UPMC Eye Center, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania , USA.
Department of Internal Medicine , UPMC Mercy Hospital , Pittsburgh, Pennsylvania , USA.
BMJ Open Diabetes Res Care. 2016 Feb 16;4(1):e000164. doi: 10.1136/bmjdrc-2015-000164. eCollection 2016.
To determine the prevalence and risk factors of diabetic retinopathy in the inpatient diabetic population in the USA and to determine the barriers to ophthalmic examinations and treatment among this population.
A cross-sectional analysis of 113 inpatients with diabetes mellitus admitted to an inner city community teaching hospital in Pittsburgh. Digital fundus photographs of the posterior pole were taken of each eye after pharmacological dilation. Presence, absence and severity of diabetic retinopathy and macular edema were graded on the basis of internationally accepted criteria. An investigator-administered questionnaire and review of the medical record were used to obtain data about patient demographics, clinical characteristics and barriers to ophthalmic care. The association between these data and the presence of diabetic retinopathy was tested.
The estimated prevalence of diabetic retinopathy in the inpatient population was 44% (95% CI 34% to 53%). The prevalence of previously undiagnosed diabetic retinopathy and sight-threatening retinopathy was 25% (95% CI 17% to 33%) and 19% (95% CI 11% to 26%), respectively. Renal disease was independently associated with the presence of diabetic retinopathy (OR, 3.86; 95% CI 1.22 to 12.27), as well as a longer duration of diabetes (OR, 1.08 per year; 95% CI 1.014 to 1.147). Diabetic retinopathy was seen in 15 of 17 patients admitted with diabetic foot ulcers or osteomyelitis. Frequently reported barriers to ophthalmic examinations included lack of transportation and physical disability.
The prevalence of diabetic retinopathy and sight-threatening diabetic retinopathy in the inpatient population is likely significantly higher than in the general diabetic population in the USA. These patients have barriers to care that need to be addressed to make standard of care ophthalmic examinations and treatment possible in this population.
在美国住院糖尿病患者人群中确定糖尿病视网膜病变的患病率和风险因素,并确定该人群中眼科检查和治疗的障碍。
对匹兹堡市一家市区教学医院收治的 113 例住院糖尿病患者进行横断面分析。对每只眼进行药物散瞳后,拍摄后极部数字眼底照片。根据国际公认的标准,对糖尿病视网膜病变和黄斑水肿的存在、缺失和严重程度进行分级。通过调查员管理的问卷和病历回顾,获取患者人口统计学、临床特征和眼科护理障碍的数据。测试这些数据与糖尿病视网膜病变之间的关联。
住院人群中糖尿病视网膜病变的估计患病率为 44%(95%CI 34%至 53%)。未确诊的糖尿病视网膜病变和威胁视力的视网膜病变的患病率分别为 25%(95%CI 17%至 33%)和 19%(95%CI 11%至 26%)。肾脏疾病与糖尿病视网膜病变的存在独立相关(OR 3.86;95%CI 1.22 至 12.27),糖尿病病程较长也与糖尿病视网膜病变相关(OR 每年 1.08;95%CI 1.014 至 1.147)。17 例因糖尿病足溃疡或骨髓炎住院的患者中,有 15 例出现糖尿病视网膜病变。经常报告的眼科检查障碍包括缺乏交通工具和身体残疾。
住院患者人群中糖尿病视网膜病变和威胁视力的糖尿病视网膜病变的患病率可能明显高于美国一般糖尿病患者人群。这些患者存在护理障碍,需要加以解决,以使该人群能够接受标准的眼科检查和治疗。